Physician profile
David M Gold
NPI 1801897657
$10,581.34
in general payments reported to CMS, 2019-2025
50 companies · $6,028 in 2025
The $6,028 reported for 2025 was more than what 91% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $650 · 2020: $226 · 2021: $514 · 2022: $621 · 2023: $1,387 · 2024: $1,155 · 2025: $6,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,098 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,097.77 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,472.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $4,969.12 | 2021-2025 | |
| Abbvie INC. | $1,505.64 | 2019-2025 | |
| Corium, LLC | $244.10 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $236.10 | 2022-2025 | Qelbree, Qelbree |
| Ipsen Biopharmaceuticals, INC | $212.06 | 2023-2025 | Bylvay |
| Shire North American Group INC | $200.00 | 2019 | |
| Xeris Pharmaceuticals, INC. | $186.11 | 2021-2024 | Gvoke Hypopen |
| Qol Medical, LLC | $173.88 | 2024-2025 | Sucraid, Sucraid |
| Janssen Biotech, INC. | $171.37 | 2025 | Tremfya, Stelara, Simponi |
| Mirum Pharmaceuticals, INC. | $169.85 | 2023-2025 | Livmarli |
| Regeneron Healthcare Solutions, INC. | $168.31 | 2022-2024 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $145.07 | 2020-2025 | Eohilia |
| Collegium Pharmaceutical, INC. | $144.56 | 2025 | Jornay Pm |
| Ucb, INC. | $136.28 | 2022-2025 | Briviact, Fintepla |
| Biomarin Pharmaceutical INC. | $134.93 | 2023-2025 | Voxzogo 1.2mg, Brineura |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $124.60 | 2021-2025 | Valtoco |
| Acadia Pharmaceuticals INC | $112.83 | 2023-2025 | Daybue |
| Alexion Pharmaceuticals, INC. | $108.95 | 2022-2025 | Koselugo, Strensiq |
| Amphastar Pharmaceuticals, INC. | $102.28 | 2024-2025 | |
| Ironshore Pharmaceuticals INC. | $101.96 | 2023-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $95.51 | 2019-2024 | Nucala |
| Abbott Laboratories | $92.30 | 2023-2025 | Freestyle Libre 3 |
| Tris Pharma INC | $90.35 | 2022-2023 | Dyanavel Xr |
| Grifols USA, LLC | $84.91 | 2025 | Xembify |
| Global Blood Therapeutics, INC. | $83.18 | 2020-2022 | |
| Ascendis Pharma Endocrinology INC | $73.04 | 2025 | Skytrofa |
| Baxter Healthcare | $66.48 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Novo Nordisk INC | $62.42 | 2024-2025 | Sogroya, Rivfloza |
| Medtronic, INC. | $59.26 | 2024 | Minimed 780g |
| Pfizer INC. | $55.71 | 2023 | |
| Ironwood Pharmaceuticals, INC | $48.50 | 2024 | |
| Azurity Pharmaceuticals, INC. | $42.95 | 2024-2025 | Zonisade, Triptodur |
| Neos Therapeutics, Lp | $34.00 | 2023-2025 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Ultragenyx Pharmaceutical INC. | $29.37 | 2021 | |
| Zealand Pharma US, INC. | $29.28 | 2021 | |
| Celltrion USA INC. | $28.40 | 2025 | Vegzelma |
| Endo USA, INC. | $27.96 | 2025 | Supprelin |
| Philips North America LLC | $23.20 | 2025 | Vest Therapy Und |
| Zogenix INC. | $22.01 | 2021 | |
| Tandem Diabetes Care, INC. | $21.41 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $18.66 | 2024 | Omnipod |
| Leadiant Biosciences, INC. | $18.35 | 2019 | |
| Phadia US INC. | $18.24 | 2023 | Immunocap |
| Aquestive Therapeutics, INC. | $18.22 | 2025 | |
| Sobi, INC | $17.89 | 2022 | |
| Arbor Pharmaceuticals, INC. | $16.77 | 2019 | |
| Jazz Pharmaceuticals INC. | $15.37 | 2022 | |
| Greenwich Biosciences, INC. | $13.96 | 2021 | |
| Aytu Biopharma, INC. | $12.90 | 2019 | |
| Cognoa, INC. | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.